Nigerian Study Shows The Use of Ivermectin Alone in Treating COVID-19 as Effective as Hydroxychloroquine, Azithromycin, and Ivermectin Combination
Photo by Soumyabrata NURPHOTO VIA GETTY IMAGES
A recent study in Nigeria shows that using Ivermectin-only (IVM) to treat COVID-19 patients is equally as effective as using the HIA triple therapy (Hydroxychloroquine, Ivermectin, and Azithromycin Combination) in all inflammatory, virological, and respiratory endpoints.
This study was set up to compare Ivermectin with Ivermectin plus HCQ+IVM (HIA) treatment.
The study design was a single-blind, randomized, parallel-group study of 2 groups of COVID-19-positive Nigerian patients with 30/31 subjects in each treatment arm.
Thirty patients received ivermectin 200 mcg/kg daily for five days and thirty-one patients received HIA triple therapy. What referred to us HIA triple therapy is the use of Hydroxychloroquine 200mg per day for three days,
